12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in healthcare stocks, with Biofrontera, Autonomix Medical, Anavex Life Sciences, Aerovate Therapeutics, MiMedx Group, and Exicure seeing gains, while Matinas BioPharma, Anika Therapeutics, Psyence Biomedical, CalciMedica, Compass Pathways, and Vaccinex experienced losses.
October 31, 2024 | 4:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Autonomix Medical's stock rose by 27.24% to $13.03, with a market cap of $15 million.
The significant price increase indicates strong investor interest, likely leading to continued short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Aerovate Therapeutics' stock rose by 22.32% to $2.68, with a market cap of $77.3 million.
The stock's increase indicates positive investor sentiment, likely resulting in short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
Anavex Life Sciences' stock increased by 22.59% to $7.0, with a market cap of $593.5 million.
The rise in Anavex's stock price suggests positive developments or investor sentiment, likely leading to short-term upward movement.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Biofrontera's stock surged by 88% to $1.76, significantly increasing its market cap to $9.7 million.
The substantial increase in Biofrontera's stock price suggests positive investor sentiment or news, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
MiMedx Group's stock increased by 22.05% to $6.95, with a market cap of $1 billion, following their Q3 earnings report.
The stock's rise post-earnings suggests positive results or outlook, likely leading to continued short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
Exicure's stock rose by 19.08% to $3.12, with a market cap of $6.7 million.
The stock's increase suggests positive investor sentiment, likely leading to short-term upward movement.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
Anika Therapeutics' stock decreased by 28.39% to $17.68 following their Q3 earnings report, with a market cap of $257.8 million.
The stock's decline post-earnings suggests disappointing results or outlook, likely leading to continued short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 85
NEGATIVE IMPACT
CalciMedica's stock declined by 24.2% to $3.64, with a market cap of $39.1 million.
The stock's decline indicates negative investor sentiment, likely resulting in continued short-term losses.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
Compass Pathways' stock fell by 23.13% to $4.76 following their Q3 earnings report, with a market cap of $325.4 million.
The stock's decline post-earnings suggests disappointing results or outlook, likely leading to continued short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 85
NEGATIVE IMPACT
Matinas BioPharma's stock plummeted by 69.1% to $0.6, with a market cap of $2.9 million.
The drastic decline suggests negative news or sentiment, likely leading to continued short-term downward pressure.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Psyence Biomedical's stock fell by 24.95% to $0.07, with a market cap of $3.8 million.
The significant decline suggests negative sentiment or news, likely leading to continued short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
Vaccinex's stock fell by 21.34% to $3.17, with a market cap of $8.8 million.
The stock's decline suggests negative sentiment or news, likely leading to continued short-term downward pressure.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70